Back

Impact of P2Y12 inhibitor pretreatment on angiographic findings and clinical outcomes in patients with ST-elevation myocardial infarction

20 February 2026 (09:45 - 10:30)
Organised by: Logo
Congress Presentation Part of: Poster session (2) - Acute coronary syndromes (2) ST-Elevation Myocardial Infarction (STEMI) EAPCI Premium Access EAPCI Summit 2026 European Association of Percutaneous Cardiovascular Interventions (EAPCI)

About the speaker

Photo
Mr Konstantinos Kalogeras

Athens Chest Hospital Sotiria, Athens (Greece)

4 More presentations in this session

Presentation thumbnail
Doctor V. Buniatyan (Yerevan, AM)
Abstract Slides
Presentation thumbnail
Doctor A. Denegri (Parma, IT)
Abstract
Presentation thumbnail
Doctor X. Krasniqi (Pristina, XK)
Abstract Slides
Presentation thumbnail

Access the full session

Session thumbnail
Poster session (2) - Acute coronary syndromes (2)

The Event

Event poster

EAPCI Summit 2026

20 February 2026 09:45 CET
You may be interested in
thumbnail
Congress Presentation
Impact of P2Y12 inhibitor pretreatment before coronary angiography in high risk NSTE-ACS: A comparative cohort analysis
21 March 2026
thumbnail
Congress Presentation
Clinical outcomes, predictors and prognostic impact of acute heart failure in patients with ST elevation myocardial infarction
21 May 2023
thumbnail
Congress Presentation
Efficacy of early intravenous landiolol, an ultrashort-acting beta-blocker on infarct size and its safety in patients with myocardial infarction undergoing primary PCI: a randomized, controlled study
28 August 2020
thumbnail
Congress Presentation
Thromboelastography-based assessment of thrombus burden in STEMI
20 March 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources